Skip to main content
NIH funding notice RFA-AI-24-029

Mechanisms of Inducing HIV Immunity in Early Life (MIEL) (U01 Clinical Trial Not Allowed)

Closed on October 9, 2024.

Posted
June 18, 2024
Close date
October 9, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,772,231 in first-year total cost, median $1,257,182.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 SA-A (M1)]3

Most frequent institutions

  1. DUKE UNIVERSITY1
  2. UNIVERSITY OF FLORIDA1
  3. WEILL MEDICAL COLL OF CORNELL UNIV1
Competing awards under RFA-AI-24-029 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025An early life multivalent immunization strategy for induction of neutralization breadth1U01AI192448-01NELSON, ASHLEY NICOLEWEILL MEDICAL COLL OF CORNELL UNIV, NY$1,275,484ZAI1
2025Leveraging prenatal tolerance to improve AAV/bNAb therapy outcomes in infancy1U01AI193791-01MARTINS, MAURICIO AUNIVERSITY OF FLORIDA, FL$1,257,182ZAI1
2025Mechanisms of Early-life Immunity Associated with HIV-1 Vaccine-induced Neutralizing Antibody Responses1U01AI192382-01BRADLEY, TODD CHRISTOPHERPOLLARA, JUSTIN JOSEPHWILLIAMS, WILTON BDUKE UNIVERSITY, NC$1,239,565ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.